COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants
COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants Researchers in the United States have demonstrated the efficacy of the vaccine INO-4800 against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19). “Here we report the neutralizing antibody and T cell activity measured in INO-4800 vaccinated subjects against emerging SARS-CoV-2 variants first detected in the United Kingdom, South Africa, and Brazil,” writes the team from Inovio Pharmaceuticals, the Wistar Institute in Philadelphia, and th...
Source: news-medical.net